| A lipidomic analysis of nonalcoholic fatty liver disease P Puri, RA Baillie, MM Wiest, F Mirshahi, J Choudhury, O Cheung, ... Hepatology 46 (4), 1081-1090, 2007 | 1468 | 2007 |
| Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—an emerging role for gut microbiome S MahmoudianDehkordi, M Arnold, K Nho, S Ahmad, W Jia, G Xie, ... Alzheimer's & Dementia 15 (1), 76-92, 2019 | 553 | 2019 |
| Metabolic network failures in Alzheimer's disease: A biochemical road map JB Toledo, M Arnold, G Kastenmüller, R Chang, RA Baillie, X Han, ... Alzheimer's & Dementia 13 (9), 965-984, 2017 | 430 | 2017 |
| Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study VR Varma, AM Oommen, S Varma, R Casanova, Y An, RM Andrews, ... PLoS medicine 15 (1), e1002482, 2018 | 418 | 2018 |
| Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis H Doege, RA Baillie, AM Ortegon, B Tsang, Q Wu, S Punreddy, D Hirsch, ... Gastroenterology 130 (4), 1245-1258, 2006 | 322 | 2006 |
| Metabolomic mapping of atypical antipsychotic effects in schizophrenia R Kaddurah-Daouk, J McEvoy, RA Baillie, D Lee, JK Yao, ... Molecular psychiatry 12 (10), 934-945, 2007 | 314 | 2007 |
| Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition RA Baillie, R Takada, M Nakamura, SD Clarke Prostaglandins, leukotrienes and essential fatty acids 60 (5-6), 351-356, 1999 | 274 | 1999 |
| Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: relationship to neuroimaging and CSF biomarkers K Nho, A Kueider-Paisley, S MahmoudianDehkordi, M Arnold, ... Alzheimer's & Dementia 15 (2), 232-244, 2019 | 268 | 2019 |
| Enteric microbiome metabolites correlate with response to simvastatin treatment R Kaddurah-Daouk, RA Baillie, H Zhu, ZB Zeng, MM Wiest, UT Nguyen, ... PLoS One 6 (10), e25482, 2011 | 234 | 2011 |
| Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers K Nho, A Kueider-Paisley, S Ahmad, S MahmoudianDehkordi, M Arnold, ... JAMA network open 2 (7), e197978-e197978, 2019 | 194 | 2019 |
| Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors SD Clarke, P Thuillier, RA Baillie, X Sha The American journal of clinical nutrition 70 (4), 566-571, 1999 | 174 | 1999 |
| Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome M Arnold, K Nho, A Kueider-Paisley, T Massaro, K Huynh, B Brauner, ... Nature communications 11 (1), 1148, 2020 | 158 | 2020 |
| Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer’s disease P Baloni, CC Funk, J Yan, JT Yurkovich, A Kueider-Paisley, K Nho, ... Cell Reports Medicine 1 (8), 2020 | 151 | 2020 |
| Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics J McEvoy, RA Baillie, H Zhu, P Buckley, MS Keshavan, HA Nasrallah, ... PloS one 8 (7), e68717, 2013 | 144 | 2013 |
| Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study R Kaddurah-Daouk, RA Baillie, H Zhu, ZB Zeng, MM Wiest, UT Nguyen, ... Metabolomics 6, 191-201, 2010 | 141 | 2010 |
| Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment M Trupp, H Zhu, WR Wikoff, RA Baillie, ZB Zeng, PD Karp, O Fiehn, ... PloS one 7 (7), e38386, 2012 | 122 | 2012 |
| Fatty acid regulation of gene expression. Its role in fuel partitioning and insulin resistance. SD Clarke, R Baillie, DB Jump, MT Nakamura Annals of the New York Academy of Sciences 827, 178-187, 1997 | 111 | 1997 |
| Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease K Huynh, WLF Lim, C Giles, KS Jayawardana, A Salim, NA Mellett, ... Nature communications 11 (1), 5698, 2020 | 106 | 2020 |
| Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease E Horgusluoglu, R Neff, WM Song, M Wang, Q Wang, M Arnold, ... Alzheimer's & Dementia 18 (6), 1260-1278, 2022 | 94 | 2022 |
| Impaired plasmalogens in patients with schizophrenia R Kaddurah-Daouk, J McEvoy, R Baillie, H Zhu, JK Yao, VL Nimgaonkar, ... Psychiatry research 198 (3), 347-352, 2012 | 88 | 2012 |
